JNJ couldn't possibly buy both Allergan and Mentor, they would be able to get by the anti-trust issues. Pfizer, despite what Crammer says, is a long-shot at best. The stock was in the 20s, but it is about to hit the 40s again, Pfiszer would have to offer something in the way of 60+ bucks a share for any shot at buying the company.
I agree Pfizer has the money, just don't think that they would be willing to pay the premium...I think it would take much more than 15 billion to buy the company, more like 18-20 billion. I agree though it would make sense for Pfizer, their pipeline looks horid.
Allergan is very stupid to allow JNJ to buy MNT so cheap, everybody is sitting on stocks that will easily be triple or more, (some worth 5 times as much) by 2010.
MNT was headed for the 100's eventually. The best breasts on this planet and selling out so cheap makes the sector look bad. Allergan would gain respect by coming out and offering at least 45 eventually for Mentor. 40 first, Analysts would say that Allergan has the experience and management to get every bit that is possible out of Mentor. Anybody that knows anything about the sector knows Mentor management was about as weak as they come, and having the best fake breast product in the entire world,Mentor shareholders got the shaft as it seems that Mentor managment just wanted to give up, they know they could get 3 times for their company in a couple of years but they don't want to wait.
Johnson and Johnson saw a steal in a weak Bush economy and were all over it like white on rice. You know Johnson and Johnson is laughing all the way to the bank at how cheap they bought Mentor,(which many think should be valued higher then Allergan)
I hope Mnt shareholders vote their shares NO or that somebody as wise as JNJ makes a higher offer, anybody can pay 45 and the stock will be 90 in a couple years!